Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. Company
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Moderna, Inc.
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows:

- Collaboration revenue (79.8%);

- Grant revenue (20.2%).

At the end of 2019, the group possessed a portfolio of 6 development candidates in clinical studies, with three in phase II and three in phase I.

Number of employees : 1 300 people.
Sales per Business
20192020Delta
Transformative Medicines60.21100%803.40100% +1234.34%
USD in Million
Sales per region
2020
United States764.5395.2%
Rest of World38.874.8%
USD in Million
Managers
Name Title Age Since
Stéphane Bancel Chief Executive Officer & Director 47 2011
Stephen Hoge President 44 2015
David Meline Chief Financial Officer 62 2020
Juan Andres Chief Technical Operations & Quality Officer 55 2017
Paul Burton Chief Medical Officer - 2021
Paul Sagan Independent Non-Executive Director 61 2018
Robert Langer Independent Non-Executive Director 71 2010
Stephen A. Berenson Independent Non-Executive Director 59 2017
Noubar Afeyan Chairman 58 2012
Francois Nader Independent Non-Executive Director 63 2019
Members of the board
Name Title Age Since
Noubar Afeyan Chairman 58 2012
Paul Sagan Independent Non-Executive Director 61 2018
Robert Langer Independent Non-Executive Director 71 2010
Stephen A. Berenson Independent Non-Executive Director 59 2017
Stéphane Bancel Chief Executive Officer & Director 47 2011
Francois Nader Independent Non-Executive Director 63 2019
Sandra J. Horning, Dr. Independent Director 71 2020
Elizabeth E. Tallett Independent Director 70 2020
Elizabeth G. Nabel, Dr. Independent Director 68 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 401,527,789 362,676,060 90.3% 0 0.0% 90.3%
Shareholders
NameEquities%
Baillie Gifford & Co. 45,337,764 11.3%
Stéphane Bancel 22,587,594 5.63%
Flagship Pioneering 20,581,016 5.13%
The Vanguard Group, Inc. 18,204,552 4.53%
Robert Langer 11,509,357 2.87%
BlackRock Fund Advisors 7,598,007 1.89%
Thélème Partners LLP 6,302,056 1.57%
SSgA Funds Management, Inc. 6,008,874 1.50%
Fidelity Management & Research Co. LLC 5,550,272 1.38%
Morgan Stanley Investment Management, Inc. 3,910,621 0.97%
Markets and indexes
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  MRNA.O
- Datastream Code :  
Company contact information
Moderna, Inc.
200 Square Technology
MA 02139 Cambridge, Massachusetts

Phone : +1 617 714 6500
Fax : +1 617 583 1998
web site : https://www.modernatx.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Moderna, Inc.
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
MODERNA, INC.231.78%139 174
LONZA GROUP AG25.60%58 688
IQVIA HOLDINGS INC.38.03%47 386
CELLTRION, INC.-26.60%31 285
SEAGEN INC.-11.93%28 062
PHARMARON BEIJING CO., LTD.72.12%24 138
CUREVAC N.V.-38.46%21 497
ALNYLAM PHARMACEUTICALS, INC.36.92%20 918
HANGZHOU TIGERMED CONSULTING CO., LTD-2.34%20 647
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.62.33%20 383
ICON PUBLIC LIMITED COMPANY26.45%19 647
BIO-TECHNE CORPORATION52.96%18 891
INCYTE CORPORATION-11.07%17 257
PPD, INC.35.42%16 280
NOVAVAX, INC.63.86%13 536
QIAGEN N.V.-0.11%12 062
PRA HEALTH SCIENCES, INC.0.00%10 965
INTELLIA THERAPEUTICS, INC.151.05%9 922
BACHEM HOLDING AG56.01%9 550
GENSCRIPT BIOTECH CORPORATION208.95%9 402
CRISPR THERAPEUTICS AG-20.10%9 322